Scopus
YÖKSİS DOI Eşleşti
SJR Q2
Does Sericin, as a Novel Pleurodesis Agent, Have Higher Effectiveness Compared to Talcum Powder, Doxycycline, and Silver Nitrate Pleurodesis?
Archivos De Bronconeumologia · Temmuz 2019
Özet
Introduction: The usefulness of sericin as pleurodesis agent has previously been described. Present study aims to compare sericin pleurodesis regarding success, effectiveness, tolerability, and side-effects. Methods: Adult, 12-week-old Wistar-albino rats (n = 60), divided to five groups as sericin, talcum-powder, doxycycline, silver-nitrate and control. Agents were administrated through left thoracotomy, rats sacrificed twelve-days after. Results: Highest ratio of collagen fibers was observed in sericin group, and the intensity was higher than talcum-powder group (p < 0.05). Compared to silver nitrate, sericin group displayed better mesothelial reaction, and multi-layer mesothelium was also better (p < 0.05). Foreign body reaction and emphysema were less frequent in sericin group (p < 0.05). The presence of biological tissue in parenchyma was less prominent in sericin group (p < 0.05). Foreign body reaction on thoracic wall was less common in sericin group (p < 0.05). Presence of biological tissue glue in thoracic wall was less prominent in sericin group (p < 0.05). Glomerular degeneration was lower in sericin group compared to the silver nitrate group (p < 0.05), and tubular degeneration was less common in sericin group than talcum group (p < 0.05). Pericarditis was less common in sericin group compared to the other groups (p < 0.05). Conclusion: As an intrinsic, natural glue protein, sericin protects the lung parenchyma and tissues, and its glue-like characteristics enable pleurodesis. The success of sericin in pleurodesis was demonstrated in the present study based on investigations of the pleurae. Being cost-effective and better tolerated agent associated with a low potential of side effects, sericin is more effective, less expensive and provides more lung parenchyma protection.
YÖKSİS Kayıtları
Does Sericin, as a Novel Pleurodesis Agent, Have Higher Effectiveness Compared to Talcum Powder, Doxycycline, and Silver Nitrate Pleurodesis?
Archivos de Bronconeumologia · 2019 SCI-Expanded
Dr. Öğr. Üyesi TUBA ŞAHİNOĞLU →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 2 kaydı bulundu.
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 2 kaydı bulundu.
Does Sericin, as a Novel Pleurodesis Agent, Have Higher Effectiveness Compared to Talcum Powder, Doxycycline, and Silver Nitrate Pleurodesis?
2019 ISSN: 0300-2896 SCI-Expanded Q3
Dr. Öğr. Üyesi TUBA ŞAHİNOĞLU →
The Efficacy and Safety of Different Sericin Doses for Pleurodesis.
2020 ISSN: 0300-2896 SCI-Expanded Q3
Dr. Öğr. Üyesi TUBA ŞAHİNOĞLU →
Makale Bilgileri
Toplam Atıf
7 atıf
· Scopus
ISSN03002896
Yayın TarihiTemmuz 2019
Cilt / Sayfa55 · 357-367
Scopus ID2-s2.0-85056831642
Kurumlar
Ankara Numune Education and Research Hospital
Ankara Turkey
Atatürk Chest Disease and Thoracic Surgery Education and Research Hospital, Ankara
Ankara Turkey
Turkiye Yuksek Ihtisas Hospital
Ankara Turkey
Zonguldak Bulent Ecevit University
Zonguldak Turkey
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 7.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
Archivos de Bronconeumologia
Q2
OA
SJR Skoru0,608
H-Index64
YayıncıSociedad Espanola de Neumologia y Cirugia Toracica (SEPAR)
ÜlkeSpain
Pulmonary and Respiratory Medicine (Q2)
Metrikler
7
Atıf